Description

Quanil (citicoline sodium) solution for oral use 100 mg/1 ml. 30 ml. №1 vial

Ingredients

Active ingredient: Citicoline sodium
Other ingredients: purified water, sodium benzoate, citric acid, sodium citrate

Dosage

Recommended dosage: As directed by a healthcare professional.
Do not exceed the recommended dose without consulting a doctor.

Indications

Quanil (citicoline sodium) solution is indicated for the treatment of cognitive impairments in various conditions such as stroke, dementia, and head trauma.

Contraindications

Do not use Quanil (citicoline sodium) solution if you are allergic to citicoline or any other ingredients in the product.
Consult your doctor before use if you are pregnant, nursing, or have any underlying medical conditions.

Directions

Shake well before use.
Take the medication orally as directed by your healthcare provider.
Do not mix with other substances.

Scientific Evidence

Citicoline, the active ingredient in Quanil, has shown promising results in various studies for its neuroprotective and cognitive-enhancing effects.
Research published in the Journal of Neural Transmission suggests that citicoline may improve cognitive function and memory in patients with cognitive impairments.

Additional Information

Storage: Store Quanil (citicoline sodium) solution at room temperature away from light and moisture.
Keep out of reach of children.

Citicoline sodium, the key component of Quanil, is known for its role in brain health and function. It works by increasing the levels of neurotransmitters, enhancing cerebral blood flow, and supporting the repair of neuronal membranes. These actions contribute to improved cognitive function and overall brain health.

In a comparative study published in the Journal of International Medical Research, citicoline was found to be more effective than placebo in improving cognitive function in patients with mild vascular cognitive impairment. The results suggest that Quanil may offer significant benefits in cognitive disorders compared to similar drugs on the market.